WebApr 9, 2024 · The firm has a market cap of $177.85 million, a P/E ratio of -0.95 and a beta of 2.22. Tenaya Therapeutics has a fifty-two week low of $1.64 and a fifty-two week high of $14.43. The firm has a 50-day simple moving average of $2.92 and a two-hundred day simple moving average of $2.65. Tenaya Therapeutics Company Profile WebApr 9, 2024 · The firm has a market cap of $177.85 million, a P/E ratio of -0.95 and a beta of 2.22. Tenaya Therapeutics has a fifty-two week low of $1.64 and a fifty-two week high of …
Tenaya Therapeutics, Inc. Common Stock (TNYA) - Nasdaq
WebMar 31, 2024 · Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. WebFeb 17, 2024 · Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the … ee online 1099 form template
Tenaya Therapeutics Market Cap
WebApr 11, 2024 · Tenaya Therapeutics stock slides 19.4% on pricing ~$75M securities offering SA NewsThu, Nov. 17, 2024 Tenaya Therapeutics slips 16% on $75M public offering SA … WebTenaya Therapeutics Stock Price Today (NASDAQ: TNYA) Quote, Market Cap, Chart WallStreetZen Tenaya Therapeutics Inc Stock Add to Watchlist Overview Forecast Earnings Dividend Ownership $3.36 +0.16 (+5%) Updated Mar 6, 2024 1W + 15.27% 1M + 13.13% 3M + 46.72% 1Y - 73.16% TNYA Price $3.36 Fair Value Price N/A Market Cap $139.02M 52 … WebTenaya Therapeutics, Inc. (TNYA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). ... Market Data powered by Barchart Solutions. Fundamental data provided by Zacks and Morningstar. contact number verification